IL6 and inflammatory bowel disease: In states of obesity and inflammatory bowel diseases, the metabolism of tryptophan is enhanced in the adipose tissue, correlating with IL6 levels [49] and leading to increased intestinal permeability and LPS translocation in the systemic circulation, resulting in peripheral inflammation, altered glucose metabolism, and impaired hepatic protection [50].